After participating in the activity, the participant should be able to:
This program is directed towards Physicians, RNs, PAs, PharmDs, Fellows and Students interested in Hematology Oncology, Medical Oncology and Internal Medicine.
Lectures, Case Studies, Panel Discussions, Poster Session, Poster Presentations, Interactive Small Groups, Question-and-Answer Sessions
A course evaluation form will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of The University of Texas MD Anderson Cancer Center and the Society of Hematologic Oncology. The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This activity been approved for 30.00 AMA PRA Category 1 Credits TM.
This continuing nursing education activity was approved by the Texas Nurses Association – Approver, an accredited approver with distinction, by the American Nurses Credentialing Center’s Commission on accreditation.
By the end of this conference the learner will be able to identify and apply the latest advances in science, pathophysiology, therapy and appropriate management to patients with hematologic malignancies based on current evidence.
Registered attendees can earn up to 26.25 contact hours, depending on sessions attended, at the Society of Hematologic Oncology 2018 Annual Meeting.